Disease Progression Modeling Workbench 360

Disease Progression Modeling (DPM)1 aims to characterize the progression of a disease and its comorbidities over time using a wide range of analytics models including disease staging2, patient trajectory analytics3, prediction4, and time-to-event estimations5 for key disease-related events. DPM has applications throughout the healthcare ecosystem, from providers (e.g., decision support for patient staging), to payers (e.g., care management), and pharmaceutical companies (e.g., clinical trial enrichment). But the complexity of building effective DPM models can be a roadblock for their rapid experimentation and adoption. Some of this is addressed by standardization of data model and tooling for data analysis and cohort selection6. However, there are still unmet needs to facilitate the development of advanced machine learning techniques such as deep learning with additional requirements such as experiment tracking and reproducibility7. Furthermore, to accelerate DPM research, a data scientist’s available tools should include a framework for deploying models as cloud-ready microservices for rapid prototyping and dissemination8.

[1]  Kenney Ng,et al.  Blending Knowledge in Deep Recurrent Networks for Adverse Event Prediction at Hospital Discharge , 2021, ArXiv.

[2]  Fabrizio Montesi,et al.  Microservices: Yesterday, Today, and Tomorrow , 2017, Present and Ulterior Software Engineering.

[3]  Yu-Chuan Li,et al.  Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers , 2015, MedInfo.

[4]  Jürgen Schmidhuber,et al.  Learning to Forget: Continual Prediction with LSTM , 2000, Neural Computation.

[5]  Luca Foschini,et al.  Reproducibility in Machine Learning for Health , 2019, RML@ICLR.

[6]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..

[7]  Aram Galstyan,et al.  Multitask learning and benchmarking with clinical time series data , 2017, Scientific Data.

[8]  Ying Li,et al.  A probabilistic disease progression modeling approach and its application to integrated Huntington’s disease observational data , 2019, JAMIA open.

[9]  Peter Szolovits,et al.  MIMIC-III, a freely accessible critical care database , 2016, Scientific Data.

[10]  Rae Woong Park,et al.  Characterizing treatment pathways at scale using the OHDSI network , 2016, Proceedings of the National Academy of Sciences.

[11]  Ying Li,et al.  Early Prediction of Diabetes Complications from Electronic Health Records: A Multi-Task Survival Analysis Approach , 2018, AAAI.

[12]  Yun Yang,et al.  A Survey of Disease Progression Modeling Techniques for Alzheimer's Diseases , 2019, 2019 IEEE 17th International Conference on Industrial Informatics (INDIN).

[13]  D. Sow,et al.  Impact of Clinical and Genomic Factors on SARS-CoV2 Disease Severity , 2021, medRxiv.

[14]  Tommi Mikkonen,et al.  Who Needs MLOps: What Data Scientists Seek to Accomplish and How Can MLOps Help? , 2021, 2021 IEEE/ACM 1st Workshop on AI Engineering - Software Engineering for AI (WAIN).